Viewing Study NCT06211335


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2025-12-28 @ 8:29 AM
Study NCT ID: NCT06211335
Status: RECRUITING
Last Update Posted: 2025-04-18
First Post: 2024-01-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Sponsor: Shyam S.D. Rao
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module